Skip to content
Review Open access

Nutritional Impairment and Muscle Health in MASLD: The Potential Role of Eating Behaviors

Oct 2026 · Journal of Clinical Medicine · Vol 15, pp. 8306 · 0 citations · 86 references

TL;DR

Findings support assessment beyond body mass index, integrating eating behaviors, nutritional risk, and muscle health, and propose an adult assessment framework.

Abstract

Obesity can conceal nutritional impairment and compromised muscle health in metabolic dysfunction-associated steatotic liver disease (MASLD). This critical narrative review examines the potential role of eating behaviors in nutritional impairment and muscle health in MASLD, focusing on adults with overweight or obesity while considering the limited findings in lean MASLD and, separately, pediatric evidence. Altered eating behaviors are associated with prevalent MASLD, but their contribution to malnutrition, myosteatosis, and sarcopenic obesity remains unproven. Nutritionally adverse dietary patterns and appetite loss may increase vulnerability, although evidence linking these factors to muscle outcomes derives predominantly from aging and general obesity populations. Total daily protein intake is better supported than specific meal-level distribution targets, while resistance exercise offers more consistent functional benefits than protein supplementation alone in the limited direct MASLD evidence. Restricting eating windows has not demonstrated additional hepatic benefit over usual care. Incretin-associated lean-mass loss does not by itself establish sarcopenia or disproportionate muscle harm and requires interpretation alongside muscle strength and function. Physical inactivity, socioeconomic circumstances, multimorbidity, and reverse causation complicate attribution to eating behavior. These findings support assessment beyond body mass index, integrating eating behaviors, nutritional risk, and muscle health. We propose an adult assessment framework; however, prospective studies are needed to validate it and clarify the independent contribution of eating behaviors to nutritional and muscle deterioration in MASLD.

Read PDF

Similar papers

Review Open access Oct 2026

GLP-1-Based Pharmacotherapies and Skeletal Muscle Health in Obesity: A Narrative Review of Body Composition, Muscle Function, and Sarcopenia-Related Outcomes

GlP-1-1-based pharmacotherapies may influence sarcopenia risk through competing pathways, whereas energy restriction, inadequate protein intake, gastrointestinal adverse effects, and lean tissue loss may increase vulnerability.

Justyna Knapik, Weronika Fic, Ewelina Polak-Szczybyło · 0 citations
Review Open access Oct 2026

Sarcopenic obesity in older adults: the dual burden of muscle loss and fat gain. Clinical consequences, diagnostic challenges, and integrated management strategies

Sarcopenic obesity is an emerging geriatric syndrome defined by the simultaneous presence of reduced skeletal muscle mass and function alongside excess adiposity. As populations age and obesity prevalence rises, this condition has grown in clinical importance, carrying risks of frailty, falls, disability, metabolic syn...

Harishchandra Chaudhari, Gaurav Chaudhary, Y. Gaikwad et al. · 0 citations
Review Open access Sep 2026

Sarcopenic Obesity in Adults: Endocrine-Metabolic Mechanisms, Body Composition, and Nutritional Strategies in the Latin American Context

Sarcopenic obesity is a complex clinical condition characterized by the coexistence of excessive adiposity and reduced skeletal muscle mass, strength, or function, generating a phenotype associated with metabolic dysfunction, physical limitation, and increased clinical vulnerability. This study aimed to analyze the end...

Dayanna Estefania Fernández Astudillo, Diana Carolina Samueza Guachamin, Margarita María De La Cadena Vinueza et al. · 0 citations
Open access Oct 2026

Management of Obesity in Liver Cirrhosis: A Delicate Balance of Risks and Benefits

Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a major global cause of chronic liver disease and is closely associated with obesity and metabolic syndrome. Obesity contributes to MASLD progression and increases the risk of liver fibrosis, cirrhosis, and hepatocellular carcinoma. However...

Seung-Kak Shin, O. S. Kwon · 0 citations
Review Open access Oct 2026

Childhood Obesity: A Systematic Review of Anatomical and Physiological Perspectives with the Role of Diet, Sleep, Physical Activity, and Lifestyle Interventions

Comprehensive and multidisciplinary approaches targeting diet, sleep, and physical activity are essential for effective prevention and long-term management of childhood obesity.

Priyanka Verma · 0 citations
Review Open access 2025

Obesity and its Comorbidities: The Role of Healthy Nutrition in Maintaining Normal Body Composition

Obesity is among the most significant public health concerns worldwide. In combination with its comorbidities, it contributes to serious health complications and, in severe cases, may result in mortality. This manuscript presents an overview of obesity and its most prevalent comorbidities. Furthermore, it discusses the...

Judit Molnár, Dávid Vasas, Mukhtar H. Ahmed · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.